Sg Americas Securities, LLC Biomarin Pharmaceutical Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 6,270 shares of BMRN stock, worth $417,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,270

Previous 7,404 15.32%

Holding current value

$417,770

Previous $610,000 27.7%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$69.02 - $93.84 $78,268 - $106,414	-1,134 Reduced 15.32%	6,270 $441,000
Q2 2024 Jul 12, 2024	SELL	$74.43 - $92.22 $2.09 Million - $2.59 Million	-28,078 Reduced 79.13%	7,404 $610,000
Q1 2024 May 06, 2024	BUY	$83.81 - $99.0 $2.97 Million - $3.51 Million	35,482 New	35,482 $3.1 Million
Q3 2023 Oct 13, 2023	SELL	$85.07 - $94.48 $246,107 - $273,330	-2,893 Reduced 36.85%	4,957 $439,000
Q2 2023 Jul 10, 2023	BUY	$86.68 - $100.3 $426,378 - $493,375	4,919 Added 167.83%	7,850 $680,000
Q1 2023 Apr 28, 2023	SELL	$87.74 - $117.27 $843,532 - $1.13 Million	-9,614 Reduced 76.64%	2,931 $285,000
Q4 2022 Feb 02, 2023	BUY	$80.93 - $108.63 $876,633 - $1.18 Million	10,832 Added 632.34%	12,545 $1.3 Million
Q3 2022 Oct 31, 2022	SELL	$82.16 - $96.94 $2.25 Million - $2.65 Million	-27,364 Reduced 94.11%	1,713 $145,000
Q2 2022 Jul 29, 2022	SELL	$71.48 - $86.85 $2.74 Million - $3.33 Million	-38,363 Reduced 56.88%	29,077 $2.41 Million
Q1 2022 Apr 29, 2022	BUY	$74.28 - $92.69 $2.8 Million - $3.5 Million	37,740 Added 127.07%	67,440 $5.2 Million
Q4 2021 Feb 07, 2022	BUY	$71.72 - $91.47 $2.02 Million - $2.58 Million	28,152 Added 1818.6%	29,700 $2.62 Million
Q3 2021 Nov 01, 2021	SELL	$74.77 - $85.47 $445,105 - $508,802	-5,953 Reduced 79.36%	1,548 $120,000
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $302,568 - $339,753	-4,007 Reduced 34.82%	7,501 $626,000
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $460,037 - $558,287	-6,156 Reduced 34.85%	11,508 $869,000
Q4 2020 Feb 04, 2021	SELL	$72.61 - $90.2 $3.18 Million - $3.95 Million	-43,792 Reduced 71.26%	17,664 $1.55 Million
Q3 2020 Nov 09, 2020	SELL	$71.87 - $131.03 $1.88 Million - $3.42 Million	-26,112 Reduced 29.82%	61,456 $4.68 Million
Q2 2020 Jul 20, 2020	BUY	$79.55 - $124.22 $6.08 Million - $9.5 Million	76,441 Added 686.99%	87,568 $10.8 Million
Q1 2020 Apr 30, 2020	SELL	$71.37 - $96.85 $227,242 - $308,370	-3,184 Reduced 22.25%	11,127 $940,000
Q4 2019 Jan 28, 2020	SELL	$64.27 - $86.37 $5.34 Million - $7.18 Million	-83,111 Reduced 85.31%	14,311 $1.21 Million
Q3 2019 Nov 04, 2019	BUY	$67.4 - $85.11 $5.57 Million - $7.04 Million	82,669 Added 560.35%	97,422 $6.57 Million
Q2 2019 Jul 29, 2019	BUY	$80.35 - $93.9 $74,805 - $87,420	931 Added 6.74%	14,753 $1.26 Million
Q1 2019 Apr 29, 2019	BUY	$84.2 - $98.62 $1.16 Million - $1.36 Million	13,822 New	13,822 $1.23 Million
Q4 2018 Feb 01, 2019	SELL	$80.14 - $106.07 $2.25 Million - $2.98 Million	-28,094 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$93.92 - $105.72 $1.78 Million - $2.01 Million	18,988 Added 208.52%	28,094 $2.72 Million
Q2 2018 Aug 07, 2018	BUY	$76.01 - $99.03 $100,865 - $131,412	1,327 Added 17.06%	9,106 $858,000
Q1 2018 May 03, 2018	BUY	$77.67 - $92.63 $79,611 - $94,945	1,025 Added 15.18%	7,779 $631,000
Q4 2017 Jan 24, 2018	BUY	$80.76 - $95.13 $417,367 - $491,631	5,168 Added 325.85%	6,754 $602,000
Q3 2017 Nov 07, 2017	BUY	$80.6 - $94.95 $127,831 - $150,590	1,586	1,586 $148,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Biomarin Pharmaceutical Inc Transaction History